Skip to main content
Top
Published in: Langenbeck's Archives of Surgery 5/2013

01-06-2013 | Review Article

Sentinel lymph node biopsy in early-stage breast cancer patients: improved survival through better staging?

Authors: Pamela Meiers, Tulin Cil, Ulrich Guller, Markus Zuber

Published in: Langenbeck's Archives of Surgery | Issue 5/2013

Login to get access

Abstract

Purpose

The objective of this review is to summarize the evidence demonstrating that the sentinel lymph node (SLN) procedure is not only associated with significantly less morbidity compared to the axillary dissection, but may also result in better staging and improved patient outcomes.

Methods

A search of MedLine and PubMed articles using the terms “sentinel lymph node biopsy”, “breast cancer”, “staging”, “morbidity”, “survival”, and “outcomes” was conducted.

Results

Breast cancer staging includes axillary evaluation as an integral component. Over the past two decades, sentinel lymph node biopsy has evolved as a technique that has an improved morbidity over traditional axillary dissection. The sentinel node(s) undergo a more intensive pathologic examination than traditional axillary contents. In the node-negative group of patients, this may have led to stage migration and potentially improved disease-free and overall survival.

Conclusion

The SLN procedure is not only associated with significantly less morbidity compared to the axillary lymph node dissection, it may also result in more accurate staging, better axillary tumor control and improved survival.
Literature
1.
go back to reference Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Eng J Med 349:353–546CrossRef Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Eng J Med 349:353–546CrossRef
2.
go back to reference McMasters KM, Tuttle TM, Carlson DJ et al (2000) Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 18(13):2560–2566PubMed McMasters KM, Tuttle TM, Carlson DJ et al (2000) Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 18(13):2560–2566PubMed
3.
go back to reference Alex JC, Krag DN (1993) Gamma-probe guided localization of lymph nodes. Surg Oncol 3:137–143CrossRef Alex JC, Krag DN (1993) Gamma-probe guided localization of lymph nodes. Surg Oncol 3:137–143CrossRef
4.
go back to reference Carlo JT, Grant MD, Knox SM et al (2005) Survival analysis following sentinel lymph node biopsy: a validation trial demonstrating its accuracy in staging early breast cancer. Proc (Bayl Univ Med Cent) 18(2):103–107 Carlo JT, Grant MD, Knox SM et al (2005) Survival analysis following sentinel lymph node biopsy: a validation trial demonstrating its accuracy in staging early breast cancer. Proc (Bayl Univ Med Cent) 18(2):103–107
5.
go back to reference Fitzgibbon PL, Page DL, Weaver D et al (1999) Prognostic factors in breast cancer: College of American Pathologists Consensus Statement. Arch Pathol Lab Med 124(7):966–978 Fitzgibbon PL, Page DL, Weaver D et al (1999) Prognostic factors in breast cancer: College of American Pathologists Consensus Statement. Arch Pathol Lab Med 124(7):966–978
6.
go back to reference Lucci A, McCall LM, Beitsch PD et al (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group trial Z0011. J Clin Oncol 25(24):3657–3663PubMedCrossRef Lucci A, McCall LM, Beitsch PD et al (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group trial Z0011. J Clin Oncol 25(24):3657–3663PubMedCrossRef
7.
go back to reference Langer I, Guller U, Berclaz G et al (2007) Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary node dissection after breast cancer surger: a prospective swiss multicenter study on 659 patients. Ann Surg 245(3):452–461PubMedCrossRef Langer I, Guller U, Berclaz G et al (2007) Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary node dissection after breast cancer surger: a prospective swiss multicenter study on 659 patients. Ann Surg 245(3):452–461PubMedCrossRef
8.
go back to reference Cox C, White L, Allred N et al (2006) Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy. Ann Surg Oncol 13(5):708–711PubMedCrossRef Cox C, White L, Allred N et al (2006) Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy. Ann Surg Oncol 13(5):708–711PubMedCrossRef
9.
go back to reference Giuliano AE, Dales PS, Turner RR et al (1995) Improved staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222(3):394–399PubMedCrossRef Giuliano AE, Dales PS, Turner RR et al (1995) Improved staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222(3):394–399PubMedCrossRef
10.
go back to reference Tan LK, Giri D, Hummer AJ et al (2008) Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. J Clin Oncol 26(11):1803–1809PubMedCrossRef Tan LK, Giri D, Hummer AJ et al (2008) Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. J Clin Oncol 26(11):1803–1809PubMedCrossRef
11.
go back to reference Dowlatshahi K, Fan M, Bloom KJ et al (1999) Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: a preliminary study. Cancer 86(6):990–996PubMedCrossRef Dowlatshahi K, Fan M, Bloom KJ et al (1999) Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: a preliminary study. Cancer 86(6):990–996PubMedCrossRef
12.
go back to reference Cummings MC, Walsh MD, Hohn BG et al (2002) Occult axillay lymph node metastases in breast cancer do matter: results of 10-year survival analysis. Am J Surg Pathol 26(10):1286–1295PubMedCrossRef Cummings MC, Walsh MD, Hohn BG et al (2002) Occult axillay lymph node metastases in breast cancer do matter: results of 10-year survival analysis. Am J Surg Pathol 26(10):1286–1295PubMedCrossRef
13.
go back to reference Rosen PP, Saigo PE, Braun DW Jr et al (1981) Predictors of recurrence in stage I (T1N0M0) breast carcinoma. Ann Surg 193(1):15–25PubMedCrossRef Rosen PP, Saigo PE, Braun DW Jr et al (1981) Predictors of recurrence in stage I (T1N0M0) breast carcinoma. Ann Surg 193(1):15–25PubMedCrossRef
14.
go back to reference Kahn HJ, Hanna WM, Chapman JA et al (2006) Biological significance of occult micrometastases in histoloically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system. Breast J 12(4):294–301PubMedCrossRef Kahn HJ, Hanna WM, Chapman JA et al (2006) Biological significance of occult micrometastases in histoloically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system. Breast J 12(4):294–301PubMedCrossRef
15.
go back to reference Bilimoria KY, Bentrem DJ, Hansen NM et al (2009) Comparison of sentinel lymph node biospy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol 27(18):2946–2953PubMedCrossRef Bilimoria KY, Bentrem DJ, Hansen NM et al (2009) Comparison of sentinel lymph node biospy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol 27(18):2946–2953PubMedCrossRef
16.
go back to reference Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis. A randomized trial. JAMA 305(6):569–575PubMedCrossRef Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis. A randomized trial. JAMA 305(6):569–575PubMedCrossRef
17.
go back to reference Feinstein AR, Sosin DM, Well CK (1985) The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in breast cancer. N Engl J Med 312(25):1604–1608PubMedCrossRef Feinstein AR, Sosin DM, Well CK (1985) The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in breast cancer. N Engl J Med 312(25):1604–1608PubMedCrossRef
18.
go back to reference Vanderveen KA, Schneider PD, Khatri VP et al (2006) Upstaging and improved survival of early stage breast cancer patients after implementation of sentinel lymph node biopsy for axillary staging. Ann Surg Oncol 13(11):1450–1456PubMedCrossRef Vanderveen KA, Schneider PD, Khatri VP et al (2006) Upstaging and improved survival of early stage breast cancer patients after implementation of sentinel lymph node biopsy for axillary staging. Ann Surg Oncol 13(11):1450–1456PubMedCrossRef
19.
go back to reference Montagna E, Viale G, Rotmensz N et al (2009) Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure. Breast Cancer Res Treat 118(2):385–394PubMedCrossRef Montagna E, Viale G, Rotmensz N et al (2009) Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure. Breast Cancer Res Treat 118(2):385–394PubMedCrossRef
20.
go back to reference Langer I, Guller U, Hsu-Schmitz SF et al (2009) Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients. Eur J Surg Oncol 35(8):805–813PubMedCrossRef Langer I, Guller U, Hsu-Schmitz SF et al (2009) Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients. Eur J Surg Oncol 35(8):805–813PubMedCrossRef
21.
go back to reference de Boer M, van Deurzen CH, van Dijck JA et al (2009) Micrometastases or isolated tumour cells and the outcome of breast cancer. N Engl J Med 361(7):653–663PubMedCrossRef de Boer M, van Deurzen CH, van Dijck JA et al (2009) Micrometastases or isolated tumour cells and the outcome of breast cancer. N Engl J Med 361(7):653–663PubMedCrossRef
22.
go back to reference Langer I, Guller U, Vieht CT et al (2009) Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early stage breast cancer patients: Long term outcomes of a prospective study. Ann Surg Oncol 16(22):3366–3374PubMedCrossRef Langer I, Guller U, Vieht CT et al (2009) Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early stage breast cancer patients: Long term outcomes of a prospective study. Ann Surg Oncol 16(22):3366–3374PubMedCrossRef
23.
go back to reference Güller U, Langer I, Zuber M (2010) In reply: micrometastases in breast cancer sentinel lymph node. Ann Surg Oncol 17:938CrossRef Güller U, Langer I, Zuber M (2010) In reply: micrometastases in breast cancer sentinel lymph node. Ann Surg Oncol 17:938CrossRef
24.
go back to reference Viehl CT, Langer I, Güller U et al (2011) Prognostic impact and therapeutic implication of sentinel lymph node micro-metastases in early stage breast cancer patients. J Surg Oncol 103(6):531–3PubMedCrossRef Viehl CT, Langer I, Güller U et al (2011) Prognostic impact and therapeutic implication of sentinel lymph node micro-metastases in early stage breast cancer patients. J Surg Oncol 103(6):531–3PubMedCrossRef
25.
go back to reference Langer I, Guller U, Viehl CT, Zuber M (2009) Sentinel lymph node metastases in breast cancer: prognostic relevance and therapeutic implications. In: Leong SPL (ed) From local invasion to metastatic cancer. Involvement of distant sites through the lymphovascular system. Humana Press, New York, pp 339–345CrossRef Langer I, Guller U, Viehl CT, Zuber M (2009) Sentinel lymph node metastases in breast cancer: prognostic relevance and therapeutic implications. In: Leong SPL (ed) From local invasion to metastatic cancer. Involvement of distant sites through the lymphovascular system. Humana Press, New York, pp 339–345CrossRef
Metadata
Title
Sentinel lymph node biopsy in early-stage breast cancer patients: improved survival through better staging?
Authors
Pamela Meiers
Tulin Cil
Ulrich Guller
Markus Zuber
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
Langenbeck's Archives of Surgery / Issue 5/2013
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-012-1037-2

Other articles of this Issue 5/2013

Langenbeck's Archives of Surgery 5/2013 Go to the issue